Pierre Fabre Laboratoires signs a sponsorship agreement with the IHU healthAge In Toulouse
12 July 2024
Pierre Fabre Laboratories signs a sponsorship agreement with the IHU HealthAge in Toulouse to identify new biological mechanisms underlying skin aging.
Toulouse, July 11, 2024 - Committed to understanding and addressing skin aging, Pierre Fabre Laboratories are extending their longstanding support to the University Hospital Center (CHU) of Toulouse and the teams led by Professor Bruno VELLAS, founding President of the Hospital-University Institute (IHU) HealthAge, through the signing of a five-year sponsorship agreement.
Significant progress has been made since 2012, particularly through the research program launched in 2020 as part of the INSPIRE T cohort, which follows over 1,000 volunteers aged 20 to 100 over a period of ten years.
We took advantage of the INSPIRE T cohort to establish a unique research program on skin aging with the CHU of Toulouse, Toulouse III-Paul Sabatier University, and Inserm, co-founders of the IHU HealthAge. The initial results obtained are very promising and represent an important step in understanding the biological mechanisms underlying skin aging.
As leading actors in anti-aging research, Pierre Fabre Laboratories will leverage these results to improve the management of skin aging. This research program with IHU HealthAge is expected to lead to the identification of predictive biomarkers of aging and transitioning to skin fragility. These results will enable the determination of a person's biological age, which is often different from their chronological age. This major advancement, based on medical research, will pave the way for the development of personalized, preventive care capable of delaying or even reversing the first signs of skin aging within Eau Thermale Avène. The iconic brand of Pierre Fabre Laboratories thus confirms its commitment to developing increasingly innovative and effective solutions based on medical research.
About Pierre Fabre Laboratories
Pierre Fabre Laboratories is the world's second-largest dermo-cosmetics company and one of Europe's leading pharmaceutical companies. Its portfolio includes several international brands and medical franchises such as Pierre Fabre Oncologie, Pierre Fabre Dermatologie, Pierre Fabre Pharma Care, Eau Thermale Avène, Ducray, A-Derma, Klorane, René Furterer, Darrow, Même Cosmetics, Naturactive, Elgydium, Inava and Arthrodont..
In 2023, Pierre Fabre Laboratories posted 2.83 billion euros in revenue, 70% of which came from international sales in 120 countries. Historically based in the southwest of France and manufacturing 95% of its products in France, Pierre Fabre Laboratories employs over 10,000 people worldwide. Its annual R&D budget amounts to nearly 200 million euros, of which about 50% is dedicated to targeted therapies in oncology and 40% to skin health and care solutions.
Pierre Fabre Laboratories' majority shareholder (86%) is the eponymous Foundation, which is recognized by the French government as being a public-interest foundation. This capital structure guarantees the company's independence and long-term vision. Dividends paid to the
Pierre Fabre Foundation enable the latter to design and finance humanitarian healthcare-access programs in developing countries. Employees are the company's secondary shareholder, through an international employee shareholding plan.
Pierre Fabre Laboratories’ sustainability policy has been assessed by the independent AFNOR Certification body and has been awarded the "Exemplary" level of its CSR label (ISO 26 000 standard for sustainable development).
For more information, visit www.pierre-fabre.com, @PierreFabreGroup.
A propos de l’IHU HealthAge
Supported by the synergy between Toulouse University Hospital, Toulouse III - Paul Sabatier University and Inserm, the IHU HealthAge is the University Hospital Institute dedicated to aging. It is the fruit of decades of work by researchers and doctors in Toulouse, determined to advance science and enable everyone to age well.
In light of the unprecedented global phenomenon where the population of people over 60 is expected to double by 2050, IHU HealthAge is positioned as a pioneer in addressing the medical, human, societal, and economic challenges of aging. In France, where the average life expectancy without disability at 65 is 12.6 years for women and 11.3 years for men in 2021, it is crucial to develop science, prevention, and innovative solutions to ensure healthy ageing. The HealthAge Institute is dedicated to advancing the understanding of the biological mechanisms of ageing and the associated pathologies.
This innovative project is supported by the State and the Regional Health Agency, as well as the long-standing support of the Occitanie Region, the Haute-Garonne Department, and the City of Toulouse. It also benefits from the support of numerous partners and sponsors: CNSA, Health Insurance, CNAV and Retirement Insurance, AXA Mutuals, Lilly France, La Poste, IRCEM, Pierre Fabre Laboratories, EDENIS, Clariane, EISAI, and EMEIS
Presse Contact
Dorothée Kohler
dorothee.kohler@pierre-fabre.com
+33 6 08 09 22 41